Regentis Biomaterials (RGNT) Enterprise Value (2024 - 2025)
Regentis Biomaterials (RGNT) posted quarterly Enterprise Value of -$7.4 million for Q4 2025, down 3121.83% year-over-year from $244156.4 in Q4 2024, and down 3121.83% quarter-over-quarter from -$229000.0 in Q4 2024.
Regentis Biomaterials (RGNT) Enterprise Value (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Enterprise Value for 2 consecutive years, with -$7.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value fell 3121.83% year-over-year to -$7.4 million; the TTM figure through Dec 2025 stood at -$7.4 million (down 3121.83% YoY), while the FY2025 annual figure was -$7.4 million, down 3121.83% from the prior year.
- Enterprise Value declined to -$7.4 million in Q4 2025 per RGNT's latest filing, from -$229000.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$229000.0 in Q4 2024 and bottomed at -$7.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Regentis Biomaterials | 1.20 Mn | -6.18 Mn | - | -7.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.38 Mn |
| Dec 31, 2024 | -229,000.00 |